Serum β2-Microglobulin and Total Sialic Acid levels in Oral Squamous Cell Carcinoma patients: A South Indian Study
Abstract
Background: Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors. Its incidence is rated as one among the highest in the world and the use of tobacco in various forms is increasingly associated with the cause of OSCC. In oral cancer the study of tumor markers have been limited and several tumor makers with clinical promise needs further evaluation.Methods: Present study was conducted in histopathologically confirmed OSCC patients form Coimbatore city, South India. Levels of β2-Microglobulin and Total Sialic Acid (TSA) in serum of the subjects were analyzed by ELISA and spectrophotometric method.Results: The levels of β2-microglobulin (3.81±0.09) and TSA (72.81±2.31) were found to be elevated in OSCC patients when compared with the controls (2.07±0.15; 64.17±1.86). Mean values were compared between the smokers and non smokers, which showed a significant increase in the level of β2-microglobulin and TSA (P < 0.05).Conclusion: In this study, the levels of β2-microglobulin and TSA were higher in OSCC patients with smoking habit than in non smokers. The study hypothesizes that this imbalance may be one of the major factors responsible for the progression of oral cancer.Ayude D, Gacio G, Cadena MP, et al. Combined use of established and novel tumor markers in the diagnosis of head and neck squamous cell carcinoma. Oncol Rep 2003; 10: 1345-1350.
Baxi BR, Patel PS, Adhvaryu SG, and Dayal PK. “Usefulness of serum glycoconjugates in precancerous andcancerous diseases of the oral cavity,†Cancer. 1991; 67(1): 135–140.
Berggard I and Bearn AG. Isolation and properties of a low molecular weight β2 –microglobulin occurring in human biological fluids. J. Biol. Chem. 1968;243: 4095-4103.
Blann AD, Kirkpatrick U, Devine C, Naser S, and Mccollum C N, “The influence of acute smoking on leucocytes, platelets and the endothelium,†Atherosclerosis. 1998; 141 (1): 133–139.
Cluette-Brown J, Mulligan J, Doyle K, Hagan S, Osmolski T, and Hojnocki J. “Oral nicotine induces an atherogenic lipoprotein profile,†Proceedings of the Society for Experimental Biology and Medicine. 1986; 182 (3):409–413.
Erbil K, Jones J D, and Klee GG. “Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer,†Cancer. 1985; 55 (2); 404–409.
Evrin PE and Wibell L. (1973) Serum β2–microglobulin in various disorders. Clin. Chim. Acta. 1973; 43: 183-187.
Kithier K, Cejka J, Belamariac J, Al-Sarraf M, Peterson WD, Vaitkevicius VK and Poulik M.D. β2–microglobulin: Occurrence in fetal life and malignancy. Clin. Chim. Acta. 1974; 52: 293-299.
Lal H. Biochemical studies in head and neck cancer. Clin Biochem 1994; 27(4): 235-43.
Latha MS, Vijayammal PL, and Kurup PA, “Changes in the glycosaminoglycans and glycoproteins in the tissues in rats exposed to cigarette smoke,†Atherosclerosis. 1991; 31: (1)49–54.
Lindberg G, Rastam L, Gullberg B, Eklund G A, and Tornberg S. Serum sialic acid concentration and smoking: a population based study. British Medical Journal. 1991; 303 (6813):1306–1307.
Lindberg G, Eklund GA, and Gullberg B. Serum sialic acid concentration and cardiovascular mortality. British Medical Journal. 1991; 302 (6769):143–146.
Manoharan S, Padmanabhan M, Kolanjiappan K, Ramachandran CR, Suresh K: Analysis of glycoconjugates in patients with oral squamous cell carcinoma. Clinica Chimica Acta 2004; 339: 91–96.
Manzar W, Raghvan MRV, Aroor AR, et al. Evaluation of serum β2-microglobulin in oral cancer. Aust Dent J 1992; 37(1): 39-42.
Mendall MA, Patel P, Asante M et al., “Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease,†Heart. 1997; 78: (3) 273–277.
Nair J, Ohshima H, Nair UJ, and Bartsch H. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Critical Reviews in Toxicology. 1996; 26: (2)149–161, 1996.
Nair U, Bartsch H, and Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis. 2004; 19: (4)251–262.
Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002; 52:195-215.
Petkowicz B, Miszczuk JW, Wojtak M, et al. The diagnostic utility of the assay of β2-microglobulin in the precancerous lesions and oral cancers. Ann Univ Mariae Curie Sklodowska 2006; XIX (1) : 243-247.
Petti S: Lifestyle risk factors for oral cancer. Oral Oncology 2009; 45: 340-350.
Plucinsky MC, Riley WM, Prorok JJ, et al. Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer 1986; 58: 2680-2685.
Rao VR, Krishnamoorthy L, Kumarswamy SV, et al. Circulating levels in serum of total sialic acid, lipid associated sialic acid and fucose in precancerous lesion and cancer of the oral cavity. Cancer Detect Prev 1998; 22(3): 237-240.
Rizzolo D, Hanifin C, Chiodo TA. Oral cancer: How to find this hidden killer in two minutes. JAAPA 2007; 20(10): 42-47.
Sankaranarayanan R, Ramadas K, Thomas G , Muwonge R, Thara S, Mathew B, Rajan B. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005; 365: 1927–33.
Sata T, Roth J, Zuber C, Stamm B, and Heitz PU. Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa: a lectingold cytochemical study with Sambucus nigra and Maackia amurensis lectins. The American Journal of Pathology. 1991; 139 (6):1435–1448.
Sebzda T, Saleh Y, Gburek J, Warwas M, Andrzejak R, Siewinski M, Rudnicki J: Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage. Journal of Experimental Therapeutics and oncology 2006; 5: 223-229.
Shuster J, Gold P. and Poulik MD. Β2–microglobulin levels in cancerous and other disease states. Clin. Chim. Acta. 1976; 67:307-313.
Sillanaukee P, ¨onni¨o MP and Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. European Journal of Clinical Investigation. 1999; 29(5):413–425.
Silvia CRWD, Vasudevan DM, Prabhu KS. Alteration of serum β2-microglobulin in oral carcinoma. Indian J Clin Biochem 2002; 17 (2): 104-7.
Silvia CRWD, Vasudevan DM, Prabhu KS. Evaluation of serum glycoproteins in oral carcinoma. Indian J Clin Biochem 2001; 16 (1): 113-115.
Vaishali N, Tupkari JV. An estimation of serum β2-microglobulin level in premalignant lesions / conditions and oral squamous cell carcinoma: A clinicopathological study. J Oral Maxillofac Pathol. 2005; 9 (1): 16-19.
| Files | ||
| Issue | Vol 5 No 1&2 (2013) | |
| Section | Original Articles | |
| Keywords | ||
| oral cancer β2-microglobulin total sialic acid smokers | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
